Literature DB >> 25247331

Risk factors: HDL-cholesterol levels and mortality in patients with ESRD.

Nosratola D Vaziri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25247331     DOI： 10.1038/nrneph.2014.169

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 2.  Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.

Authors:  Baohai Shao; Michael N Oda; John F Oram; Jay W Heinecke
Journal:  Curr Opin Cardiol       Date:  2006-07       Impact factor: 2.161

3.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

4.  Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Authors:  Hamid Moradi; Elani Streja; Moti L Kashyap; Nosratola D Vaziri; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

5.  Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.

Authors:  Hirokazu Honda; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Tetsuo Michihata; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Journal:  Atherosclerosis       Date:  2011-11-03       Impact factor: 5.162

6.  Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.

Authors:  Suguru Yamamoto; Patricia G Yancey; T Alp Ikizler; W Gray Jerome; Ryohei Kaseda; Brian Cox; Aihua Bian; Ayumi Shintani; Agnes B Fogo; Macrae F Linton; Sergio Fazio; Valentina Kon
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

Review 7.  Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

Authors:  N D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2006-02

Review 8.  HDL metabolism and activity in chronic kidney disease.

Authors:  Nosratola D Vaziri; Mohamad Navab; Alan M Fogelman
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

Review 9.  Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  J Ren Nutr       Date:  2010-09       Impact factor: 3.655

10.  HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

Authors:  Günther Silbernagel; Bernd Genser; Christiane Drechsler; Hubert Scharnagl; Tanja B Grammer; Tatjana Stojakovic; Vera Krane; Eberhard Ritz; Christoph Wanner; Winfried März
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121
  10 in total
  3 in total

1.  HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.

Authors:  Chantal Kopecky; Sanam Ebtehaj; Bernd Genser; Christiane Drechsler; Vera Krane; Marlies Antlanger; Johannes J Kovarik; Christopher C Kaltenecker; Mojtaba Parvizi; Christoph Wanner; Thomas Weichhart; Marcus D Säemann; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

Review 2.  HDL abnormalities in nephrotic syndrome and chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

3.  Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process.

Authors:  Jae-Yong Kim; Eun-Young Lee; Jin Kyun Park; Yeong Wook Song; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.